Status
ACTIVE
Global HQ
California, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
Industries
- Pharma
- Biotechnology
- Climate Tech
- Clean Tech
- Deep Tech
About
MarsBio is a pioneering biology company dedicated to empowering innovative bioscience entrepreneurs during their formative stages. With a strong emphasis on synthetic biology, biotechnology, and deep tech, MarsBio operates as a venture capital fund that strategically invests in pre-seed and seed stage companies. Our mission is to foster transformative ideas and technologies that can reshape the future of healthcare, agriculture, and environmental sustainability. By providing not only financial support but also strategic guidance and industry expertise, MarsBio is committed to cultivating the next generation of bioscience solutions.
MarsBio is a pioneering biology company dedicated to empowering innovative bioscience entrepreneurs during their formative stages. With a strong emphasis on synthetic biology, biotechnology, and deep tech, MarsBio operates as a venture capital fund that strategically invests in pre-seed and seed stage companies. Our mission is to foster transformative ideas and technologies that can reshape the future of healthcare, agriculture, and environmental sustainability. By providing not only financial support but also strategic guidance and industry expertise, MarsBio is committed to cultivating the next generation of bioscience solutions.
Investment Thesis
Backing the boldest bioscience entrepreneurs at the earliest stages
Manager's Experience
With a robust background in venture capital, the fund manager has successfully invested in over 50 deals, primarily targeting early-stage companies across the biotechnology and healthcare sectors. Their strategic approach emphasizes data-driven decision-making and operator-first principles, ensuring a strong alignment with portfolio companies. Noteworthy exits in the U.S. and European markets highlight a proven track record of delivering exceptional returns. The manager's thematic focus on innovative therapeutics and digital health positions them well in an evolving landscape.